Stocks/DIS

DIS three-lens brief

Evidence-based stock research on DIS. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of Jul 10
$92.19$96.09$123.40

Performance

1W
-3.4%
1M
-3.4%
3M
-3.1%
6M
-17.1%
YTD
-15.5%
1Y
-21.0%
3Y
5Y
DIS · Nightly brief
Inspect

50-day MA below 200-day MA (death-cross regime); price below both. · Trading at 12% of its 52-week range — deep in the lower band.

  • Trading at 12% of its 52-week range — deep in the lower band.
  • 50-day MA below 200-day MA (death-cross regime); price below both.
  • Underperforming SPY by 8.2pp over 30 days.
  • Analyst mean target $129.67 — 35% above current (29 analysts).
  • Earnings scheduled 2026-08-05.

DIS closed at $96.09 (-0.08%) as of 2026-07-10. Market cap: $166.86B. P/E (trailing) 15.4. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $129.67 — 35% above current (29 analysts).. Concerns: trading at 12% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $25.17B, net income $2.25B, free cash flow $3.75B. Watching for: 2026-08-05 earnings release (25 days out).

Market ✓· Fundamentals ✓· 2 events· Sentiment ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on DIS, not one.

A single reasoning model has blind spots it doesn’t know about. We examine DISacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/DIS"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath DIS brief"></iframe>